L
Lineage Cell Therapeutics Inc
F:BT3
Lineage Cell Therapeutics Inc
F:BT3
Price:
1.076
EUR
7.17%
Market Closed
Market Cap:
€203.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
Isetan Mitsukoshi Holdings Ltd
F:4HP
|
JP |
|
E
|
Experian PLC
XMUN:J2B
|
IE |
|
U
|
United Microelectronics Corp
F:UMCB
|
TW |
|
N
|
Norfolk Southern Corp
XMUN:NFS
|
US |
|
L
|
Lowe's Companies Inc
XMUN:LWE
|
US |
|
Pattern SpA
MIL:PTR
|
IT |
|
T
|
Telefonaktiebolaget LM Ericsson
XMUN:ERCB
|
SE |
|
Syntec Technology Co Ltd
TWSE:7750
|
TW |
|
L
|
Lamar Advertising Co
XBER:6LA
|
US |
|
I
|
Ingredion Inc
F:CNP
|
US |
|
B
|
Brown & Brown Inc
DUS:BTW
|
US |
|
W
|
Wayfair Inc
F:1WF
|
US |
Multiples-Based Value
The Multiples-Based Value for Lineage Cell Therapeutics Inc (BT3) under the Base Case is hidden EUR. Compared with the current market price of 1.076 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BT3 Multiples-Based Value
LOCKED
